Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bladder Cancer

  Free Subscription


19.11.2018

1 Acad Radiol
1 Ann Hematol
1 Balkan Med J
1 Biomed Res Int
5 Bladder Cancer
2 BMC Cancer
1 Cancer Manag Res
1 Cancer Res
1 Eur Urol Oncol
2 Histopathology
1 Integr Cancer Ther
3 J Cell Biochem
1 J Clin Oncol
1 J Exp Clin Cancer Res
1 Onco Targets Ther
1 PLoS One
2 Prog Urol
1 Urology
1 World J Urol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acad Radiol

  1. CHA KH, Hadjiiski PhD LM, Cohan Md RH, Chan PhD HP, et al
    Diagnostic Accuracy of CT for Prediction of Bladder Cancer Treatment Response with and without Computerized Decision Support.
    Acad Radiol. 2018 Nov 10. pii: S1076-6332(18)30474.
    PubMed     Text format     Abstract available


    Ann Hematol

  2. CAMMAERT T, Decaestecker K, Sundahl N, Rottey S, et al
    A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors?
    Ann Hematol. 2018;97:545-546.
    PubMed     Text format    


    Balkan Med J

  3. UCAR M, Demirkaya M, Aytac Vuruskan B, Balkan E, et al
    Urothelial Carcinoma of the Bladder in Pediatric Patient: Four Case Series and Review of the Literature
    Balkan Med J. 2018;35:268-271.
    PubMed     Text format     Abstract available


    Biomed Res Int

  4. KRAJEWSKI W, Mazur M, Poterek A, Pastuszak A, et al
    Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer.
    Biomed Res Int. 2018;2018:7598632.
    PubMed     Text format     Abstract available


    Bladder Cancer

  5. RIMAR KJ, Glaser AP, Kundu S, Schaeffer EM, et al
    Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer.
    Bladder Cancer. 2018;4:411-418.
    PubMed     Text format     Abstract available

  6. BRENNAN K, Karim S, Doiron RC, Siemens DR, et al
    Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based Study.
    Bladder Cancer. 2018;4:419-428.
    PubMed     Text format     Abstract available

  7. INGERSOLL MA, Li X, Inman BA, Greiner JW, et al
    Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer.
    Bladder Cancer. 2018;4:429-440.
    PubMed     Text format     Abstract available

  8. MESSING EM
    Perioperative Blood Transfusions and Bladder Cancer Outcomes.
    Bladder Cancer. 2018;4:445-446.
    PubMed     Text format    

  9. DE JONG JJ, Hendricksen K, Rosier M, Mostafid H, et al
    Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients.
    Bladder Cancer. 2018;4:395-401.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. ZHOU T, Li HY, Xie WJ, Zhong Z, et al
    Association of Glutathione S-transferase gene polymorphism with bladder Cancer susceptibility.
    BMC Cancer. 2018;18:1088.
    PubMed     Text format     Abstract available

  11. WANG Z, Xiao H, Wei G, Zhang N, et al
    Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model.
    BMC Cancer. 2018;18:1108.
    PubMed     Text format     Abstract available


    Cancer Manag Res

  12. GUO Y, Cai K, Mao S, Zhang J, et al
    Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study.
    Cancer Manag Res. 2018;10:4789-4804.
    PubMed     Text format     Abstract available


    Cancer Res

  13. OOKI A, Del Carmen Rodriguez Pena M, Marchionni L, Dinalankara W, et al
    YAP1 and COX2 Coordinately Regulate Urothelial Cancer Stem-like Cells.
    Cancer Res. 2018;78:168-181.
    PubMed     Text format     Abstract available


    Eur Urol Oncol

  14. ANARI F, O'Neill J, Choi W, Chen DYT, et al
    Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.
    Eur Urol Oncol. 2018;1:54-60.
    PubMed     Text format     Abstract available


    Histopathology

  15. TCHRAKIAN N, Browne E, Shanks JH, Flynn RJ, et al
    Phyllodes tumour of the urinary bladder: a report of a unique case.
    Histopathology. 2018;72:356-358.
    PubMed     Text format    

  16. BROWN NA, Lew M, Weigelin HC, Weizer AZ, et al
    Comparative study of TERT promoter mutation status within spatially, temporally and morphologically distinct components of urothelial carcinoma.
    Histopathology. 2018;72:354-356.
    PubMed     Text format    


    Integr Cancer Ther

  17. SU CC, Chen NC, Chyau CC, Tseng HC, et al
    Induction of Mitotic Catastrophe via Inhibition of Aurora B by Ionizing Radiation With Additive of Mulberry Water Extract in Human Bladder Cancer Cells.
    Integr Cancer Ther. 2018 Nov 15:1534735418808586. doi: 10.1177/1534735418808586.
    PubMed     Text format     Abstract available


    J Cell Biochem

  18. ZHOU X, Zhang P, Han H, Lei H, et al
    Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway.
    J Cell Biochem. 2018 Nov 11. doi: 10.1002/jcb.27938.
    PubMed     Text format     Abstract available

  19. HE YH, Deng YS, Peng PX, Wang N, et al
    A novel messenger RNA and long noncoding RNA signature associated with the progression of nonmuscle invasive bladder cancer.
    J Cell Biochem. 2018 Nov 13. doi: 10.1002/jcb.28089.
    PubMed     Text format     Abstract available

  20. XU Z, Huang B, Zhang Q, He X, et al
    NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p.
    J Cell Biochem. 2018 Nov 13. doi: 10.1002/jcb.27954.
    PubMed     Text format     Abstract available


    J Clin Oncol

  21. COEN JJ, Zhang P, Saylor PJ, Lee CT, et al
    Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
    J Clin Oncol. 2018 Nov 15:JCO1800537. doi: 10.1200/JCO.18.00537.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  22. ZHAN Y, Chen Z, Li Y, He A, et al
    Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA.
    J Exp Clin Cancer Res. 2018;37:273.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  23. WANG L, Yang X, Li D, Liang Z, et al
    The elevated glutaminolysis of bladder cancer and T cells in a simulated tumor microenvironment contributes to the up-regulation of PD-L1 expression by interferon-gamma.
    Onco Targets Ther. 2018;11:7229-7243.
    PubMed     Text format     Abstract available


    PLoS One

  24. BERLE M, Ghila L, Vethe H, Chaudhry A, et al
    Novel protein signatures suggest progression to muscular invasiveness in bladder cancer.
    PLoS One. 2018;13:e0206475.
    PubMed     Text format     Abstract available


    Prog Urol

  25. TRABELSSI M, Thuret R, Droupy S, Costa P, et al
    [Postoperative C-reactive protein is a reliable marker to detect complications after radical cystectomy].
    Prog Urol. 2018;28:282-290.
    PubMed     Text format     Abstract available

  26. ZIOUZIOU I, Irani J, Wei JT, Karmouni T, et al
    Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis.
    Prog Urol. 2018;28:241-250.
    PubMed     Text format     Abstract available


    Urology

  27. HUGAR LA, Yabes JG, Turner RM 2nd, Fam MM, et al
    Rate and Determinants of Completing Neoadjuvant Chemotherapy in Medicare Beneficiaries with Bladder Cancer: A SEER-Medicare Analysis.
    Urology. 2018 Nov 10. pii: S0090-4295(18)31136.
    PubMed     Text format     Abstract available


    World J Urol

  28. FANTINI D, Meeks JJ
    Genomic classification and risk stratification of bladder cancer.
    World J Urol. 2018 Nov 12. pii: 10.1007/s00345-018-2558.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: